Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990750 · ClinicalTrials.gov registry record · NA
Single Port Insufflation RCT
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06990750 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 70 participants.
The verdict
NCT06990750, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if decreasing insufflation pressure during minimally invasive single port robotic sacrocolpopexy improved postoperative pain without impacting surgeon intraoperative visualization. The main question it aims to answer is: Does minimally decreasing insufflation pressure improve postoperative pain? Researchers will compare standard insufflation pressure (15 mmHg) to experimental insufflation pressure (12 mmHg) to see if it insufflation pressure impacts patient's postoperative pain. Once a participants agrees to participate in our study, they will receive either standard or experimental pressure at the time of surgery. Postoperative pain scores in the postoperative anesthesia care unit and at postoperative day 1 and 14 visits will be recorded. Participants will also be asked to complete the Patient Global Impression of Improvement at the 14 day visit.
Interventions
- PROCEDURE 15 mmHg
- PROCEDURE 12 mmHg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06990750
The ClinicalTrials.gov registry entry for NCT06990750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 15 mmHg is the first listed.
NCT06990750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06990750 about?
NCT06990750 is a clinical study titled "Single Port Insufflation RCT". The goal of this clinical trial is to learn if decreasing insufflation pressure during minimally invasive single port robotic sacrocolpopexy improved postoperative pain without impacting surgeon intraoperative visualization. The main question it aims to answer is: Does minimally decreasing insuffla...
What is the current status of trial NCT06990750?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-01. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06990750?
The interventions under investigation include: 15 mmHg (PROCEDURE), 12 mmHg (PROCEDURE).
Who is sponsoring clinical trial NCT06990750?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.